BTIG Downgrades Biogen (BIIB) to Neutral

March 21, 2019 9:34 AM
BTIG analyst Thomas Shrader downgraded Biogen (NASDAQ: BIIB) from Buy to Neutral.The analyst comments "Earlier this morning, Biogen announced the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles